Dr. Jack Erter MD

Recommended Articles

• Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of Chemo

  In some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...

• Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery

  It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...

• 'Sophie the Brave' Fights Childhood T-Cell Lymphoma

  The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...

• The Lymphoma Research Foundation's Light it Red for Lymphoma Night

  Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...